Global Synthetic Hormones Market: Focus on Product Type, Application, Route of Administration, End User, Region, and Competitive Landscape - Analysis and Forecast, 2023-2033

November 2023 | | ID: GF81B780A8E1EN
BIS Research Inc.

Abstracts

This report will be delivered in 7-10 working days.

Introduction t%li%Global Synthetic Hormones Market

The global synthetic hormones market plays a crucial role in the healthcare and pharmaceutical industry, as synthetic hormones are widely used for various therapeutic purposes. These hormones are artificially created compounds designed t%li%mimic the effects of naturally occurring hormones in the human body. They find applications in a wide range of medical conditions, including hormone replacement therapy, contraception, and treatment of endocrine disorders.

Market Segmentation:

Segmentation 1: by Product Type

• Steroid Hormones
• Peptide Hormones
• Amin%li%Acid Derivatives
• Others

Segmentation 2: by Route of Administration

• Oral
• Topical
• Nasal
• Intravenous
• Others

Segmentation 3: by Application

• Growth Hormone Deficiency
• Male Hypogonadism
• Menopause
• Thyroid Hormone Deficiency
• Other Applications

Segmentation 4: by End User

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

Segmentation 5: by Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East and Africa

The market for synthetic hormones is global, with North America, Europe, Asia-Pacific, and other regions contributing significantly. Factors such as healthcare infrastructure, regulatory frameworks, and demographic trends influence regional market dynamics.

How can this report add value t%li%an organization?

Growth/Marketing Strategy: The global synthetic hormones market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint venture. The favored strategy for the companies has been a business expansion t%li%strengthen their positions in the synthetic hormones market.

Competitive Strategy: A detailed competitive benchmarking of the players operating in the global synthetic hormones market has been done t%li%help the reader understand how players stack against each other, presenting a clear market landscape. Additionally, comprehensive competitive strategies such as partnerships, agreements, and collaborations will aid the reader in understanding the untapped revenue pockets in the market.

Some of the prominent names established in this market are:

• Eli Lilly and Company
• Pfizer, Inc.
• Ferring B.V.
• Merck & Co., Inc
• Nov%li%Nordisk
• Acerus Pharmaceutical Corp.
• Ipsen
• Lupin Pharmaceuticals, Inc.
• Bayer
• Novartis AG
• AbbVie, Inc.
• GeneScience Pharmaceuticals
• Perrigo

Contents

1. GLOBAL SYNTHETIC HORMONES MARKET: MARKET OUTLOOK

1.1 Product Definition
1.2 Inclusion and Exclusion Criteria
1.3 Key Findings

2. GLOBAL SYNTHETIC HORMONES MARKET: INDUSTRY OUTLOOK

2.1 Key Trends
2.2 Regulatory Framework and Reimbursement Scenario
  2.2.1 Regulations in North America
  2.2.2 International Markets (Outside of the U.S.)
2.3 Patent Analysis
  2.3.1 Awaited Technological Developments
  2.3.2 Patent Analysis (By Country)
  2.3.3 Patent Analysis (By Year)

3. MARKET DYNAMICS

3.1 Impact Analysis
3.2 Market Drivers
3.3 Market Restraints
3.4 Market Opportunities

4. GLOBAL SYNTHETIC HORMONES MARKET (BY PRODUCT TYPE)

4.1 Overview
4.2 Steroid Hormones
4.3 Peptide Hormones
4.4 Amino Acid Derivatives
4.5 Others

5. GLOBAL SYNTHETIC HORMONES MARKET (BY ROUTE OF ADMINISTRATION)

5.1 Overview
5.2 Oral
5.3 Topical
5.4 Nasal
5.5 Intravenous
5.6 Others

6. GLOBAL SYNTHETIC HORMONES MARKET (BY APPLICATION)

6.1 Overview
6.2 Growth Hormone Deficiency
6.3 Male Hypogonadism
6.4 Menopause
6.5 Thyroid Hormone Deficiency
6.6 Other Applications

7. GLOBAL SYNTHETIC HORMONES MARKET (BY END USER)

7.1 Overview
7.2 Hospital Pharmacies
7.3 Retail Pharmacies
7.4 Online Pharmacies

8. GLOBAL SYNTHETIC HORMONES MARKET, BY REGION

8.1 North America Synthetic Hormones Market
  8.1.1 Market Dynamics
  8.1.2 Market Forecast and Sizing
    8.1.2.1 North America Synthetic Hormones Market (by Country)
      8.1.2.1.1 U.S.
      8.1.2.1.2 Canada
8.2 Europe Synthetic Hormones Market
  8.2.1 Key Findings and Opportunity Assessment Market Dynamics
  8.2.2 Market Forecast and Sizing
    8.2.2.1 Europe Synthetic Hormones Market (by Country)
      8.2.2.1.1 Germany
      8.2.2.1.2 France
      8.2.2.1.3 U.K.
      8.2.2.1.4 Italy
      8.2.2.1.5 Spain
      8.2.2.1.6 Rest-of-Europe
8.3 Asia-Pacific Synthetic Hormones Market
  8.3.1 Key Findings and Opportunity Assessment
  8.3.2 Market Dynamics
  8.3.3 Market Forecast and Sizing
    8.3.3.1 Asia-Pacific Synthetic Hormones Market (by Country)
      8.3.3.1.1 Japan
      8.3.3.1.2 China
      8.3.3.1.3 Australia
      8.3.3.1.4 South Korea
      8.3.3.1.5 India
      8.3.3.1.6 Rest-of-Asia-Pacific
8.4 Latin America
  8.4.1 Market Dynamics
  8.4.2 Market Forecast and Sizing
    8.4.2.1 Latin America Synthetic Hormones Market (by Country)
      8.4.2.1.1 Mexico
      8.4.2.1.2 Brazil
      8.4.2.1.3 Rest-of-Latin America
8.5 Middle East and Africa
  8.5.1 Market Dynamics
  8.5.2 Market Forecast and Sizing
    8.5.2.1 Middle East and Africa Synthetic Hormones Market (by Country)
      8.5.2.1.1 U.A.E.
      8.5.2.1.2 K.S.A
      8.5.2.1.3 South Africa
      8.5.2.1.4 Rest-of-Middle East and Africa

9. COMPETITIVE BENCHMARKING AND COMPANY PROFILES

9.1 Global Synthetic Hormones Market Active Players Ecosystem
9.2 Competitive Landscape
  9.2.1 Key Strategies and Developments
    9.2.1.1 Partnerships, Collaborations, and Business Expansions
    9.2.1.2 Mergers and Acquisitions
    9.2.1.3 Funding Activities
    9.2.1.4 New Offerings
    9.2.1.5 Regulatory and Legal Activities
9.3 Company Profiles
  9.3.1 Eli Lilly and Company
    9.3.1.1 Company overview
    9.3.1.2 Role of Eli Lilly and Company in the Global Synthetic Hormones Market
    9.3.1.3 Product Portfolio
    9.3.1.4 Financials
    9.3.1.5 Key Developments
    9.3.1.6 Analyst Perception
  9.3.2 Pfizer, Inc.
  9.3.3 Ferring B.V.
  9.3.4 Merck & Co., Inc
  9.3.5 Novo Nordisk
  9.3.6 Acerus Pharmaceutical Corp.
  9.3.7 Ipsen
  9.3.8 Lupin Pharmaceuticals, Inc.
  9.3.9 Bayer
  9.3.10 Novartis AG
  9.3.11 AbbVie, Inc.
  9.3.12 GeneScience Pharmaceuticals
  9.3.13 Perrigo
  9.3.14 Other Companies
*Note: the list of companies is tentative, it may change during research
**Note: The Financials will be provided for the public companies only